Serum NGAL and FGF23 may have certain value in early diagnosis of CIN

Aims: This study aimed to assess whether neutrophil gelatinase-associated lipocalin (NGAL) and fibroblast growth factor 23 (FGF23) could be reliable biomarkers for early diagnosis of contrast-induced nephropathy (CIN). Methods: 202 patients who underwent percutaneous coronary intervention (PCI) were...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Huihui, Yu, Zaixin, Gan, Lu, Peng, Ling, Zhou, Qiaoling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2018
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6171456/
https://www.ncbi.nlm.nih.gov/pubmed/30278796
http://dx.doi.org/10.1080/0886022X.2018.1487860

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6171456/
https://www.ncbi.nlm.nih.gov/pubmed/30278796
http://dx.doi.org/10.1080/0886022X.2018.1487860

Ejemplares similares